Андрология и генитальная хирургия (Nov 2014)
Use of the drug Selzinc plus in men with impaired fertility
Abstract
The rate of male infertility is about 40 % and has a recent upward trend. Male infertility is a multifactorial disorder. There have been recently a great number of medicaments used to treat male infertility.The investigation was undertaken to evaluate the efficacy and safety of Selzinc plus used in the combination therapy of idiopathic male infertility. The paper gives the results of therapy with Selzinc plus (a tablet b.i.d. for 3 months). The trace elements as the drug’s components have different positive effects and can improve the key parameters of a spermogram. Our investigation has confirmed the efficacy of Selzinc plus in the combination therapy of patients with idiopathic infertility. Therapy with Selzinc plus is safe even if it is given in a double daily dose.The results of this investigation and their comparability with the data available in the foreign literature enable us to recommend Selzinc for clinical application in the combination therapy of male infertility and in the programs of assisted reproductive technologies.